chr19-54939682-C-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001127255.2(NLRP7):​c.1137G>C​(p.Lys379Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00241 in 1,612,818 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. K379K) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0039 ( 12 hom., cov: 31)
Exomes 𝑓: 0.0023 ( 55 hom. )

Consequence

NLRP7
NM_001127255.2 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2O:1

Conservation

PhyloP100: -6.88
Variant links:
Genes affected
NLRP7 (HGNC:22947): (NLR family pyrin domain containing 7) This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0070764422).
BP6
Variant 19-54939682-C-G is Benign according to our data. Variant chr19-54939682-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 97715.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, not_provided=1, Benign=2}.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00389 (591/152008) while in subpopulation EAS AF = 0.00857 (44/5132). AF 95% confidence interval is 0.00656. There are 12 homozygotes in GnomAd4. There are 435 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLRP7NM_001127255.2 linkc.1137G>C p.Lys379Asn missense_variant Exon 4 of 11 NP_001120727.1 Q8WX94-3
NLRP7NM_001405531.1 linkc.1137G>C p.Lys379Asn missense_variant Exon 6 of 13 NP_001392460.1
NLRP7NM_139176.4 linkc.1137G>C p.Lys379Asn missense_variant Exon 4 of 11 NP_631915.2 Q8WX94-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLRP7ENST00000592784.6 linkc.1137G>C p.Lys379Asn missense_variant Exon 4 of 11 1 ENSP00000468706.1 Q8WX94-3

Frequencies

GnomAD3 genomes
AF:
0.00389
AC:
591
AN:
151890
Hom.:
12
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00855
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0441
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000853
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00501
AC:
1248
AN:
249060
AF XY:
0.00483
show subpopulations
Gnomad AFR exome
AF:
0.000127
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00190
Gnomad EAS exome
AF:
0.0113
Gnomad FIN exome
AF:
0.0400
Gnomad NFE exome
AF:
0.000989
Gnomad OTH exome
AF:
0.00312
GnomAD4 exome
AF:
0.00225
AC:
3290
AN:
1460810
Hom.:
55
Cov.:
74
AF XY:
0.00226
AC XY:
1639
AN XY:
726734
show subpopulations
Gnomad4 AFR exome
AF:
0.0000897
AC:
3
AN:
33444
Gnomad4 AMR exome
AF:
0.000246
AC:
11
AN:
44684
Gnomad4 ASJ exome
AF:
0.00180
AC:
47
AN:
26130
Gnomad4 EAS exome
AF:
0.0161
AC:
638
AN:
39700
Gnomad4 SAS exome
AF:
0.000650
AC:
56
AN:
86214
Gnomad4 FIN exome
AF:
0.0379
AC:
2017
AN:
53216
Gnomad4 NFE exome
AF:
0.000358
AC:
398
AN:
1111932
Gnomad4 Remaining exome
AF:
0.00196
AC:
118
AN:
60320
Heterozygous variant carriers
0
260
521
781
1042
1302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00389
AC:
591
AN:
152008
Hom.:
12
Cov.:
31
AF XY:
0.00585
AC XY:
435
AN XY:
74306
show subpopulations
Gnomad4 AFR
AF:
0.0000723
AC:
0.000072317
AN:
0.000072317
Gnomad4 AMR
AF:
0.000197
AC:
0.000196618
AN:
0.000196618
Gnomad4 ASJ
AF:
0.00173
AC:
0.00172811
AN:
0.00172811
Gnomad4 EAS
AF:
0.00857
AC:
0.00857366
AN:
0.00857366
Gnomad4 SAS
AF:
0.00104
AC:
0.00103993
AN:
0.00103993
Gnomad4 FIN
AF:
0.0441
AC:
0.0440732
AN:
0.0440732
Gnomad4 NFE
AF:
0.000854
AC:
0.000853544
AN:
0.000853544
Gnomad4 OTH
AF:
0.00238
AC:
0.00237643
AN:
0.00237643
Heterozygous variant carriers
0
28
57
85
114
142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00115
Hom.:
426
ExAC
AF:
0.00446
AC:
541
EpiCase
AF:
0.000382
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hydatidiform mole, recurrent, 1 Uncertain:1Other:1
-
Unité médicale des maladies autoinflammatoires, CHRU Montpellier
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Prostate cancer Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NLRP7: BP4, BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.0060
DANN
Benign
0.94
DEOGEN2
Benign
0.17
T;.;T;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0075
N
MetaRNN
Benign
0.0071
T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.6
L;L;L;L;L
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-3.4
D;D;.;.;.
REVEL
Benign
0.12
Sift
Benign
0.057
T;T;.;.;.
Sift4G
Benign
0.29
T;T;T;T;T
Polyphen
0.0090
B;B;B;.;.
Vest4
0.47
MVP
0.12
MPC
0.29
ClinPred
0.0064
T
GERP RS
-2.5
Varity_R
0.11
gMVP
0.64
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10418277; hg19: chr19-55451050; API